Harel Insurance Investments & Financial Services Ltd. Heron Therapeutics, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$6.11 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 27, 2021	SELL	$14.49 - $20.72 $144,900 - $207,200	-10,000 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$14.61 - $22.14 $146,100 - $221,400	10,000 New	10,000 $681,000

Others Institutions Holding HRTX

# of Institutions

173

Shares Held

114M

Call Options Held

Put Options Held

32.4K

Rubric Capital Management LP New York, NY

26.7M
Shares

$45.9 Million
0.68% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.5M
Shares

$14.6 Million
0.02% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$14.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.16M
Shares

$14 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$12 Million
22.07% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $204M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account